Kobayashi Pharmaceutical Co., Ltd.

Tokyo Stock Exchange 4967.T

Kobayashi Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 397.66 M

Kobayashi Pharmaceutical Co., Ltd. Current Liabilities is USD 397.66 M for the year ending December 31, 2023, a 0.68% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • Kobayashi Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 394.99 M, a -10.31% change year over year.
  • Kobayashi Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 440.41 M, a -9.17% change year over year.
  • Kobayashi Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 484.89 M, a -1.36% change year over year.
  • Kobayashi Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 491.58 M, a -2.40% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 4967.T

Kobayashi Pharmaceutical Co., Ltd.

CEO Mr. Satoshi Yamane
IPO Date Jan. 4, 2001
Location Japan
Headquarters KDX Kobayashi Doshomachi Building
Employees 3,534
Sector Consumers Staples
Industries
Description

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

Similar companies

2267.T

Yakult Honsha Co.,Ltd.

USD 18.28

-0.45%

4452.T

Kao Corporation

USD 39.83

-0.67%

4911.T

Shiseido Company, Limited

USD 16.86

-1.51%

8113.T

Unicharm Corporation

USD 7.83

-1.48%

4922.T

KOSÉ Corporation

USD 44.37

-1.60%

StockViz Staff

February 3, 2025

Any question? Send us an email